(HG) Hamilton Insurance - Overview
Sector: Financial Services | Industry: Insurance - Reinsurance | Exchange: NYSE (USA) | Market Cap: 3.160m USD | Total Return: 63.4% in 12m
Avg Turnover: 13.3M
Qual. Beats: 5
Rev. Trend: 93.1%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Hamilton Insurance Group, Ltd. (HG) is a Bermuda-based specialty insurance and reinsurance provider operating through three primary platforms: Hamilton Global Specialty, Hamilton Select, and Hamilton Re. The company maintains a diversified portfolio covering casualty, property, and specialty risks, including niche lines such as cyber, satellite, and political violence. Its global footprint allows it to underwrite risks across multiple jurisdictions, catering to both treaty and facultative markets.
The reinsurance business model relies on geographic and risk-class diversification to mitigate the impact of catastrophic events on capital reserves. In the current market, specialty insurers often benefit from hard market conditions, characterized by increased premiums and stricter underwriting terms due to heightened global volatility. For a deeper look into these fundamental drivers, investors can review the latest metrics on ValueRay.
Founded in 2013, Hamilton employs a data-driven approach to risk assessment across its diverse product suite, which includes professional liability, marine, and energy coverage. The company’s structure integrates traditional reinsurance with insurance-linked securities and third-party capital management to optimize its balance sheet efficiency.
- Underwriting profitability across Hamilton Global Specialty and Hamilton Re platforms
- Net investment income growth from high-yield fixed income portfolios
- Catastrophe loss exposure impacts quarterly earnings and capital reserves
- Expansion of US E&S business through Hamilton Select platform
- Favorable reinsurance pricing cycles drive gross written premium growth
| Net Income: 629.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 1.58 > 1.0 |
| NWC/Revenue: -194.7% < 20% (prev 33.63%; Δ -228.4% < -1%) |
| CFO/TA 0.09 > 3% & CFO 908.3m > Net Income 629.3m |
| Net Debt (-805.7m) to EBITDA (875.7m): -0.92 < 3 |
| Current Ratio: 0.14 > 1.5 & < 3 |
| Outstanding Shares: last quarter (101.5m) vs 12m ago 0.0% < -2% |
| Gross Margin: 49.49% > 18% (prev 0.38%; Δ 4.91k% > 0.5%) |
| Asset Turnover: 31.84% > 50% (prev 24.34%; Δ 7.50% > 0%) |
| Interest Coverage Ratio: 44.40 > 6 (EBITDA TTM 875.7m / Interest Expense TTM 19.4m) |
| A: -0.57 (Total Current Assets 955.5m - Total Current Liabilities 6.60b) / Total Assets 9.86b |
| B: 0.16 (Retained Earnings 1.60b / Total Assets 9.86b) |
| C: 0.09 (EBIT TTM 859.8m / Avg Total Assets 9.10b) |
| D: 0.22 (Book Value of Equity 1.59b / Total Liabilities 7.11b) |
| Altman-Z'' = -2.36 = D |
| DSRI: 0.34 (Receivables 1.15b/2.36b, Revenue 2.90b/2.03b) |
| GMI: 0.77 (GM 49.49% / 37.87%) |
| AQI: 3.97 (AQ_t 0.90 / AQ_t-1 0.23) |
| SGI: 1.43 (Revenue 2.90b / 2.03b) |
| TATA: -0.03 (NI 629.3m - CFO 908.3m) / TA 9.86b) |
| Beneish M = -1.74 (Cap -4..+1) = CCC |
As of May 23, 2026, the stock is trading at USD 31.86 with a total of 401,395 shares traded.
Over the past week, the price has changed by -0.91%,
over one month by -2.86%,
over three months by +9.01% and
over the past year by +63.41%.
Hamilton Insurance has received a consensus analysts rating of 3.83. Therefore, it is recommended to buy HG.
- StrongBuy: 1
- Buy: 3
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 33.9 | 6.3% |
P/S = 1.0918
P/B = 1.1251
Revenue TTM = 2.90b USD
EBIT TTM = 859.8m USD
EBITDA TTM = 875.7m USD
Long Term Debt = 149.7m USD (from longTermDebt, last fiscal year)
Short Term Debt = unknown (none)
Debt = 149.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -805.7m USD (calculated: Debt 149.8m - CCE 955.5m)
Enterprise Value = 2.35b USD (3.16b + Debt 149.8m - CCE 955.5m)
Interest Coverage Ratio = 44.40 (Ebit TTM 859.8m / Interest Expense TTM 19.4m)
EV/FCF = 2.59x (Enterprise Value 2.35b / FCF TTM 908.3m)
FCF Yield = 38.58% (FCF TTM 908.3m / Enterprise Value 2.35b)
FCF Margin = 31.34% (FCF TTM 908.3m / Revenue TTM 2.90b)
Net Margin = 21.71% (Net Income TTM 629.3m / Revenue TTM 2.90b)
Gross Margin = 49.49% ((Revenue TTM 2.90b - Cost of Revenue TTM 1.46b) / Revenue TTM)
Gross Margin QoQ = 56.95% (prev 55.56%)
Tobins Q-Ratio = 0.24 (Enterprise Value 2.35b / Total Assets 9.86b)
Interest Expense / Debt = 12.93% (Interest Expense 19.4m / Debt 149.8m)
Taxrate = 1.06% (2.32m / 219.4m)
NOPAT = 850.7m (EBIT 859.8m * (1 - 1.06%))
Current Ratio = 0.14 (Total Current Assets 955.5m / Total Current Liabilities 6.60b)
Debt / Equity = 0.06 (Debt 149.8m / totalStockholderEquity, last quarter 2.72b)
Debt / EBITDA = -0.92 (Net Debt -805.7m / EBITDA 875.7m)
Debt / FCF = -0.89 (Net Debt -805.7m / FCF TTM 908.3m)
Total Stockholder Equity = 2.69b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.91% (Net Income 629.3m / Total Assets 9.86b)
RoE = 23.38% (Net Income TTM 629.3m / Total Stockholder Equity 2.69b)
RoCE = 30.26% (EBIT 859.8m / Capital Employed (Equity 2.69b + L.T.Debt 149.7m))
RoIC = 26.06% (NOPAT 850.7m / Invested Capital 3.26b)
WACC = 9.05% (E(3.16b)/V(3.31b) * Re(8.87%) + D(149.8m)/V(3.31b) * Rd(12.93%) * (1-Tc(0.01)))
Discount Rate = 8.87% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -68.03 | Cagr: -3.61%
[DCF] Terminal Value 75.74% ; FCFF base≈799.4m ; Y1≈916.3m ; Y5≈1.35b
[DCF] Fair Price = 283.8 (EV 18.1b - Net Debt -805.7m = Equity 18.9b / Shares 66.5m; r=9.05% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 1.31 | # QB: 5
Revenue Correlation: 93.07 | Revenue CAGR: 33.57% | SUE: 1.98 | # QB: 1
EPS current Quarter (2026-06-30): EPS=1.14 | Chg30d=-3.89% | Revisions=-25% | Analysts=6
EPS next Quarter (2026-09-30): EPS=0.74 | Chg30d=-6.49% | Revisions=-25% | Analysts=6
EPS current Year (2026-12-31): EPS=4.55 | Chg30d=+7.94% | Revisions=+27% | GrowthEPS=-6.0% | GrowthRev=-5.3%
EPS next Year (2027-12-31): EPS=4.70 | Chg30d=-2.01% | Revisions=+14% | GrowthEPS=+3.3% | GrowthRev=+9.6%
[Analyst] Revisions Ratio: +27%